Changes to Medicine Use Reviews
Guidance for Medicine Use Reviews (MURs) has changed.
From 1 October 2019 until 31 March 2020, at least 70% of MURs should be carried out with patients who:
- are taking a high risk medicine (non-steroidal anti-inflammatory drug, anticoagulants including low molecular weight heparin, antiplatelets and diuretics)
- have had changes made to their medication and have been discharged from hospital within the last 8 weeks
The NHS Business Services Authority (NHSBSA) publishes a list of the drugs classed as High Risk medicines, as well as the drugs that fall under the New Medicine Service medicines. This list is refreshed on a monthly basis to include any new products which fall under these categories. Visit the NHSBSA website for more information and to access the updated list.
Contact Information
Kate Blush
Senior Media and Campaigns Officer
NHS Business Services Authority
Notes to editors
About the NHS Business Services Authority
The NHS Business Services Authority is a Special Health Authority and an Arm’s Length Body of the Department of Health and Social Care which provides a range of critical central services to NHS organisations, NHS contractors, patients and the public. Its purpose is to be a catalyst for better health and its vision is to be the delivery partner of choice for the NHS. For more information about the NHSBSA, please visit www.nhsbsa.nhs.uk